Elevated plasma levels of TGF-beta1 in patients with locally advanced breast cancer related to other clinical stages
Background: The application of plasma tumor markers is mainly during the follow-up of cancer patients and especially in monitoring of advanced disease. These biomarkers do not require surgical intervention and provide relatively simple monitoring at any time during the disease course. TGF-beta1 is a...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Institute of Oncology, Sremska Kamenica, Serbia
2003-01-01
|
Series: | Archive of Oncology |
Subjects: | |
Online Access: | http://www.doiserbia.nb.rs/img/doi/0354-7310/2003/0354-73100303131T.pdf |